Skip to main content

Advertisement

Log in

Quality of metabolic control, serum potassium, and aging are the major determinants of severity of musculoskeletal disorders in hospitalized diabetic patients

  • Original Article
  • Published:
International Journal of Diabetes in Developing Countries Aims and scope Submit manuscript

Abstract

Background

Diabetes is strongly associated with numerous musculoskeletal disorders (MSD) and may be considered as another group of diabetic complications.

Objective

We explored the association of diabetes type, duration, quality of metabolic control, applied therapy, and serum electrolytes, with prevalence and extent of musculoskeletal disorders as well as radiographic and EMG changes.

Methods

The case-control clinical study involved 80 patients with type 1 and 2 diabetes hospitalized at General Hospital Berane and Clinical Center Podgorica, Montenegro, in 2013. More than half of the diabetics had MSD. Peripheral nerve disorders were diagnosed by EMG. The musculoskeletal disorders were evaluated using the translated Short Musculoskeletal Function Assessment (SMFA) questionnaire. The statistical methodology involved T-testing, χ2 test, Spearman’s multiple correlation, and ordinal logistic regression.

Results

The incidence and the severity of MSD were significantly related to patients age, duration of diabetes, quality of metabolic control, serum potassium, radiographic, and EMG findings. However, in the regression analysis, only aging, mean blood glucose levels, and serum potassium were associated with the significant risk for development of MSD.

Conclusion

Advanced age, metabolic control, and hypokalemia are the main determinants of both prevalence and extent of musculoskeletal disorders in diabetics. Along with the strict glycemic control, an additional effort should be taken to avoid potassium depletion associated with diabetic ketoacidosis and to maintain optimal potassium homeostasis in diabetic patients receiving insulin, diuretics, or suffer gastrointestinal motility disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Data availability

The research data and materials available at: https://1drv.ms/x/s!AnToNOskCFMggehCKd16jy4nmNTj6g

References

  1. Dashora UK. Musculoskeletal features of diabetes mellitus. Int J Diab Dev Countries. 1994;14:129–33.

    Google Scholar 

  2. Douloumpakas I, Pyrpasopoulou A, Triantafyllou A, Sampanis C, Aslanidis S. Prevalence of musculoskeletal disorders in patients with type 2 diabetes mellitus: a pilot study. Hippokratia. 2007;11(4):216–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  3. Wyatt LH, Ferrance RJ. The musculoskeletal effects of diabetes mellitus. Can Chiropr Assoc. 2006;50(1):43–50.

    Google Scholar 

  4. Singla R, Gupta I, Kalra S. Musculoskeletal effects of diabetes mellitus. J Pak Med Assoc. 2015;1024–1027.

  5. Arkkila PE, Gautier J-F. Musculoskeletal disorders in diabetes mellitus: an update. Best Pract Res Clin Rheumatol. 2003;17(6):945–70.

    Article  CAS  Google Scholar 

  6. Singh AK. Musculoskeletal disorder in type 2 diabetes mellitus. Natl J Med Allied Sci. 2014;3(2):48–56.

    Google Scholar 

  7. Antony DJ. Musculoskeletal complications of diabetes and relation to glycemic control. J Med Sci Clin Res. 2017;5(10).

  8. World Medical Association. Declaration of Helsinki: ethical principles for medical research involving human subjects. Bull World Health Organ. 2001;79(4).

  9. Swiontkowski MF, Engelberg R, Martin DP, Agel J. Short musculoskeletal function assessment questionnaire. J Bone Joint Surg. 1999;81(9):1245–60.

    Article  CAS  Google Scholar 

  10. Scott DJ, Watson JDB, Heafner TA, Clemens MS, Propper BW, Arthurs ZM. Validation of the Short Musculoskeletal Function Assessment in patients with battlefield-related extremity vascular injuries. J Vasc Surg. 2014;60(6):1620–6.

    Article  Google Scholar 

  11. Larkin ME, Barnie A, Braffett BH, Cleary PA, Diminick L, Harth J, et al. Musculoskeletal complications in type 1 diabetes. Diabetes Care. 2014;37(7):1863–9.

    Article  Google Scholar 

  12. Mustafa KN, Khader YS, Bsoul AK, Ajlouni K. Musculoskeletal disorders of the hand in type 2 diabetes mellitus: prevalence and its associated factors. Int J Rheum Dis. 2015;19(7):730–5.

    Article  Google Scholar 

  13. Cagliero E, Apruzzese W, Perlmutter GS, Nathan DM. Musculoskeletal disorders of the hand and shoulder in patients with diabetes mellitus. Am J Med. 2002;112(6):487–90.

    Article  Google Scholar 

  14. Rosenbloom AL, Silverstein JH, Lezotte DC, Richardson K, McCallum M. Limited joint mobility in childhood diabetes mellitus indicates increased risk for microvascular disease. New Engl J Med. 1981;305:191–4.

    Article  CAS  Google Scholar 

  15. Gupta M. P3 fraction: effect on HbA1c values by HPLC. J Clin Diagn Res. 2016.

  16. Crispin JC, Alcocer-Varela J. Rheumatologic manifestations of diabetes mellitus. Am J Med. 2003;114(9):753–7.

    Article  Google Scholar 

  17. Bhat TA, SAr D, Dar TA, Naikoo MA, Naqqash MA, Bhat A, et al. The musculoskeletal manifestations of type 2 diabetes mellitus in a Kashmiri population. Int J Health Sci (Qassim). 2016;10(1):55–66.

    Article  Google Scholar 

  18. Sarkar P, Pain S, Sarkar RN, Ghosal R, Mandal SK, Banerjee R. Rheumatological manifestations in diabetes mellitus. J Indian Med Assoc. 2008;106:593–4.

    CAS  PubMed  Google Scholar 

  19. Majjad A, Errahali Y, Toufik H, Djossou JH, Ghassem MA, Kasouati J, et al. Musculoskeletal disorders in patients with diabetes mellitus: a cross-sectional study. Int J Rheumatol. 2018;2018:1–6.

    Article  Google Scholar 

  20. Yu-Yahiro JA. Electrolytes and their relationship to normal and abnormal muscle function. Orthop Nurs. 1994;13(5):38–40.

    Article  CAS  Google Scholar 

  21. Sjøgaard G, Mccomas AJ. Role of interstitial potassium. Adv Exp Med Biol Fatigue. 1995;69–80.

  22. Abbas H, Kothari N, Bogra J. Hypokalemic periodic paralysis. Nat J Maxillofac Surg. 2012;3(2):220–1.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

ANJ and SMJ composed the manuscript and wrote it including the tables.

JM and AJ identified the patients, took the medical history data, and filled in the forms.

LJS and BSJ performed the rheumatologic and radiologic diagnostic.

TS and VA and performed the endocrinologic diagnostic.

RDR and NM did the statistical tests and interpretations.

Corresponding author

Correspondence to Jovanovic N. Aleksandar.

Ethics declarations

Ethical approval

The survey was conducted respecting ethical principles for human clinical trials by the Declaration of Helsinki of 1983 [8] The study was approved by Ethical Committee, Faculty of Medicine, University of Pristina/K.Mitrovica.

Informed consent

All patients gave their written consent to use data from the medical documentation gathered during their hospitalization period for the research purposes.

Conflict of interest

The authors declared that they have no conflict of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Aleksandar, J.N., Smilic, L., Smilic, T. et al. Quality of metabolic control, serum potassium, and aging are the major determinants of severity of musculoskeletal disorders in hospitalized diabetic patients. Int J Diabetes Dev Ctries 40, 296–302 (2020). https://doi.org/10.1007/s13410-019-00776-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13410-019-00776-5

Keywords

Navigation